GOLDMEDICS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GOLDMEDICS
Largest movements
- Receivables within one year +€347,744
up €347,744 (+219%), from €158,622 to €506,366
of which Other amounts receivable: +€291,833
- Current investments -€300,000
down €300,000 (-100%), from €300,000 to €0
- Cash -€62,090
down €62,090 (-29.1%), from €213,506 to €151,416
mainly Receivables within one year (-€347,744) and Other debts (-€334,525)
- Stocks and contracts -€17,669
down €17,669 (-17.8%), from €99,381 to €81,712
- Other debts -€334,525
down €334,525 (-80.7%), from €414,506 to €79,981
- Reserves +€175,322
up €175,322 (+62.9%), from €278,869 to €454,190
- Trade debts +€113,038
up €113,038 (+236%), from €47,973 to €161,011
- Tax, wage and social debts +€13,956
up €13,956 (+135%), from €10,355 to €24,312
- Financial charges -€7,776
down €7,776 (-91.7%), from €8,482 to €705
- Gross operating margin +€2,640
up €2,640 (+1.1%), from €229,940 to €232,580
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €771,703 | €739,494 | -€32,209 | -4.2% |
| Current assets | 29/58 | €771,703 | €739,494 | -€32,209 | -4.2% |
| Stocks and contracts in progress | 3 | €99,381 | €81,712 | -€17,669 | -17.8% |
| Stocks | 30/36 | €99,381 | €81,712 | -€17,669 | -17.8% |
| Amounts receivable within one year | 40/41 | €158,622 | €506,366 | +€347,744 | +219% |
| Trade receivables | 40 | €152,060 | €207,971 | +€55,911 | +36.8% |
| Other amounts receivable | 41 | €6,562 | €298,395 | +€291,833 | +4,447% |
| Current investments | 50/53 | €300,000 | €0 | -€300,000 | -100% |
| Cash at bank and in hand | 54/58 | €213,506 | €151,416 | -€62,090 | -29.1% |
| Deferred charges and accrued income | 490/1 | €194 | €0 | -€194 | -100% |
| Total equity and liabilities | 10/49 | €771,703 | €739,494 | -€32,209 | -4.2% |
| Equity | 10/15 | €298,869 | €474,190 | +€175,322 | +58.7% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Reserves | 13 | €278,869 | €454,190 | +€175,322 | +62.9% |
| Distributable reserves | 133 | €278,869 | €454,190 | +€175,322 | +62.9% |
| Amounts payable | 17/49 | €472,835 | €265,304 | -€207,531 | -43.9% |
| Amounts payable within one year | 42/48 | €472,835 | €265,304 | -€207,531 | -43.9% |
| Trade debts | 44 | €47,973 | €161,011 | +€113,038 | +236% |
| Suppliers | 440/4 | €47,973 | €161,011 | +€113,038 | +236% |
| Taxes, remuneration and social security | 45 | €10,355 | €24,312 | +€13,956 | +135% |
| Taxes | 450/3 | €10,355 | €24,312 | +€13,956 | +135% |
| Other amounts payable | 47/48 | €414,506 | €79,981 | -€334,525 | -80.7% |
| Other operating charges | 640/8 | €388 | €1,132 | +€744 | +192% |
| Gross operating margin | 9900 | €229,940 | €232,580 | +€2,640 | +1.1% |
| Operating profit (loss) | 9901 | €229,552 | €231,448 | +€1,896 | +0.8% |
| Financial income | 75/76B | €4,328 | €3,136 | -€1,192 | -27.5% |
| Recurring financial income | 75 | €4,328 | €3,136 | -€1,192 | -27.5% |
| Financial charges | 65/66B | €8,482 | €705 | -€7,776 | -91.7% |
| Recurring financial charges | 65 | €8,482 | €705 | -€7,776 | -91.7% |
| Profit (loss) for the period before taxes | 9903 | €225,399 | €233,879 | +€8,480 | +3.8% |
| Income taxes | 67/77 | €57,695 | €58,557 | +€863 | +1.5% |
| Profit (loss) for the period | 9904 | €167,704 | €175,322 | +€7,618 | +4.5% |
| Profit (loss) for the period to be appropriated | 9905 | €167,704 | €175,322 | +€7,618 | +4.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.